Bmc Infectious Diseases

SCI SCIE

国际简称：BMC INFECT DIS 参考译名：Bmc 传染病

主要研究方向：医学-传染病学非预警期刊审稿周期：约1.0个月

《Bmc 传染病》(Bmc Infectious Diseases)是一本由BioMed Central出版的以医学-传染病学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
2000 年发文量
3.2 IF影响因子
开放是否OA
88 H-index
2001 创刊年份
Irregular 出版周期
English 出版语言

BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.

[ 查看全部 ]

投稿咨询加急咨询

Bmc Infectious Diseases期刊信息

ISSN：1471-2334
出版语言：English
是否OA：开放
E-ISSN：1471-2334
出版地区：ENGLAND
是否预警：否
出版商：BioMed Central
出版周期：Irregular
创刊时间：2001
开源占比：0.9933
Gold OA文章占比：99.98%
OA被引用占比：1
出版国人文章占比：0.16
出版撤稿占比：0.0010...
研究类文章占比：90.95%

Bmc Infectious Diseases CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.6

0.983

1.155

学科类别	分区	排名	百分位
大类：Medicine 小类：Infectious Diseases	Q2	134 / 361	63%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Bmc Infectious Diseases中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	INFECTIOUS DISEASES 传染病学	3区

Bmc Infectious Diseases JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：INFECTIOUS DISEASES	SCIE	Q2	55 / 141	61.3
学科：INFECTIOUS DISEASES	SCIE	Q2	43 / 141	69.86

Bmc Infectious Diseases历年数据统计

影响因子

中科院分区

Bmc Infectious Diseases中国学者发文选摘

1、Streptomyces morookaense spinal suppurative infection: a case repor
Author: Wu, Liyang; Pu, Jiahao; Xi, Xinhua; Bao, Yongzhen; Luo, Lincong

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13238-1
2、Rapid pulmonary calcification within 10 days in a COVID-19 patient: a case repor
Author: Li, Jie; Liu, Peng; Wei, Tong; Zhang, Yanan; Li, Mengjie

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13204-x
3、Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic randomised controlled tria
Author: Zhang, Yilin; Li, Yang; Ren, Yan; Li, Ting; Xing, Yajiao; Wu, Jiqin; Ren, Pengfei; Sun, Feng; Zhang, Wenhong

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13017-y
4、A Bayesian estimator of the real-time case fatality rate in emerging pandemic to inform public health policy-makin
Author: Zhang, Hengtao; Lee, Chun Yin; Qu, Yuanke

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13088-x
5、Risk prediction models for postoperative complications of urosepsis in patients with upper urinary calculi: a systematic review and meta-analysi
Author: Wang, Jinyang; Wu, Rang; Zhang, Cuilian; Cao, Xuefeng; Wang, Feng; Zhang, Xiaoting

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13066-3
6、Factors associated with preterm birth and low birth weight among syphilis-infected pregnant wome
Author: Chen, Huan; Fan, Xiaolan; Zhang, Bei; Wang, Jinlian; Liao, Wenbo; Fu, Jin

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13077-0
7、Is procalcitonin superior to CRP and ESR in the diagnosis of diabetic foot osteomyelitis? A systematic review and meta-analysi
Author: Mei, Shasha; Chen, Hua; Dai, Jiezhi

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13071-6
8、Prognostic value of dynamic procalcitonin (PCT-Δ) for adverse outcomes in patients with pyogenic liver abscess: a retrospective cohort stud
Author: Chen, Xiaoling; Yang, Juan; Hong, Xiaoli; Li, Li; Zheng, Guanghui; Yu, Tao

Journal: BMC INFECTIOUS DISEASES. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12879-026-13086-z